In February the Canadian Thoracic Society published a comprehensive report called The Human and Economic Burden of COPD. The report points out that COPD is the most underdiagnosed chronic disease in our society yet is the leading consumer of hospital beds and health care dollars.
The average admission for an acute exacerbation of COPD lasts 10 days and costs $10000. These are Canadian data and Canadian dollars. Recent research has suggested that up to 10% of Canadians have COPD, which the CTS defines as “a respiratory disorder largely caused by smoking, characterized by progressive, partially reversible airway obstruction and lung hyperinflation, systemic manifestations, and increasing frequency and severity of exacerbations.”
There is a movement in respiratory medicine to call a COPD exacerbation a “lung attack” to call attention to the seriousness of such an event and the implications it has for patient morbidity and mortality. When lung attacks result in hospitalization, they carry the same mortality as a heart attack: 8% die during the hospitalization and 25% die within the following 12 months.
There is overwhelming data that show decreased hospitalizations from good, comprehensive COPD care, including smoking cessation, pulmonary rehabilitation, and appropriate medications. Yet few patients receive such care due to lack of diagnosis, lack of comprehensive COPD clinics, and lack of recognition of the cost of this disease.
COPD is not difficult or expensive to diagnose. Spirometry done pre- and post-bronchodilators can make the diagnosis in the vast majority of cases—this costs less than $50 and should be available in most hospitals in Canada. It is recommended that any present or ex-smoker over the age of 40 with any respiratory symptom be sent for spirometry as a screen for COPD because the sooner a diagnosis is made and appropriate care begun, the better the prognosis.
This report challenges everyone in the health care system—administrators, physicians, and patients—to become more aware of the huge human and economic burden of COPD and to act now.
Above is the information needed to cite this article in your paper or presentation. The International Committee
of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally
accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
About the ICMJE and citation styles
The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.
An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.
BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:
- Only the first three authors are listed, followed by "et al."
- There is no period after the journal name.
- Page numbers are not abbreviated.
For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org